Back to top

Image: Bigstock

Company News For Jan 2, 2020

Read MoreHide Full Article
  • Shares of Neovasc Inc. NVCN soared nearly 37% after the company announced that it had submitted a premarket approval application to the U.S. Food and Drug Administration for Neovasc Reducer, used in treatment of refractory angina
  • Shares of Viveve Medical, Inc. (VIVE - Free Report) jumped 46.5% after the company announced that it has regained compliance with Nasdaq listing rules
  • Shares of Seadrill Limited SDRL rose 7.2% after the company reported that it has received a 3-year contract for AOD II and AOD III, which is expected to be $98 million and $101 million in value
  • Shares of Urovant Sciences Ltd. UROV rose 18.4% after the company reported submission of New Drug Application for Vibegron, used for the treatment of overactive bladder

In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Viveve Medical, Inc. (VIVE) - free report >>